2014
DOI: 10.1107/s1399004714001497
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of an industrial production suspension ofBacillus lentussubtilisin crystals by powder diffraction: a powerful quality-control tool

Abstract: A microcrystalline suspension of Bacillus lentus subtilisin (Savinase) produced during industrial large-scale production was analysed by X-ray powder diffraction (XRPD) and X-ray single-crystal diffraction (MX). XRPD established that the bulk microcrystal sample representative of the entire production suspension corresponded to space group P212121, with unit-cell parameters a = 47.65, b = 62.43, c = 75.74 Å, equivalent to those for a known orthorhombic crystal form (PDB entry 1ndq). MX using synchrotron beamli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…On the contrary, powder diffraction has long been employed for characterizing crystalline, nanocrystalline, and amorphous powders of pharmaceutical importance, and due to the development of extensive databases, materials can be analyzed efficiently and in a high-throughput manner by their diffraction pattern. , Preliminary structural information, such as phase identification and characterization of unit-cell parameters, is also readily available from macromolecular powder samples. ,,, ,,,,,, Microcrystalline formulations provide enhanced bioavailability as well as increased stability and unique dissolution characteristics compared to amorphous or “in solution” counterparts. Although there are numerous attempts in the literature toward the development of macromolecular microcrystalline formulations, the only successful large-scale example remains that of human insulin.…”
Section: Case Studiesmentioning
confidence: 99%
“…On the contrary, powder diffraction has long been employed for characterizing crystalline, nanocrystalline, and amorphous powders of pharmaceutical importance, and due to the development of extensive databases, materials can be analyzed efficiently and in a high-throughput manner by their diffraction pattern. , Preliminary structural information, such as phase identification and characterization of unit-cell parameters, is also readily available from macromolecular powder samples. ,,, ,,,,,, Microcrystalline formulations provide enhanced bioavailability as well as increased stability and unique dissolution characteristics compared to amorphous or “in solution” counterparts. Although there are numerous attempts in the literature toward the development of macromolecular microcrystalline formulations, the only successful large-scale example remains that of human insulin.…”
Section: Case Studiesmentioning
confidence: 99%
“…Molecular replacement was performed using the published 1.4 Å resolution crystal structure of wild-type Savinase (PDB accession code: 4CFY) as the search model (Frankaer et al, 2014). Refinement was performed by PHENIX (Liebschner et al, 2019), to establish preliminary single-conformer structures for the RT and cryogenic crystals.…”
Section: Initial Structure Calculation and Refinementmentioning
confidence: 99%
“…The substrate specificity is low but hydrophobic residues are favoured at positions P1 and P4 of the substrate (Schechter & Berger, 1967). In the structure of Savinase, two structural metal binding sites are found to be occupied by Na + and Ca 2+ (Frankaer et al, 2014).…”
Section: Introductionmentioning
confidence: 98%
“…X-ray powder diffraction (XRPD) permits the analysis of microcrystals as an ensemble. XRPD has already been successfully employed for the structural characterization of proteins (Von Dreele et al, 2000;Basso et al, 2005;Margiolaki et al, 2007Margiolaki et al, , 2013Margiolaki & Wright, 2008;Karavassili et al, 2017) and peptides (Inouye & Kirschner, 2006;Fujii et al, 2011;Fili et al, 2019), resulting in medium-resolution models ($2.5-5 Å ), as well as for crystal and polymorph screening (Margiolaki et al, 2005;Norrman et al, 2006;Hartmann et al, 2010;Hunter et al, 2011;Karavassili et al, 2012;Frankaer et al, 2014;Das et al, 2015;Valmas et al, 2015Valmas et al, , 2018Fili et al, 2015Fili et al, , 2016Trampari et al, 2018;Spiliopoulou et al, 2020). The method is ideal for the identification (Collings et al, 2010), refinement and quantification of multiple protein polymorphs coexisting in the same sample (Basso et al, 2005).…”
Section: Introductionmentioning
confidence: 99%